CRSP
#1261
CRISPR Therapeutics AG - Common Shares
59.3 7 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.24%
Monthly Change
+25.20%
6 month change
+2.29%
Year Change
+12.08%
Previous Close
59.2 3
Open
59.3 7
Low
59.3 7
High
59.3 7
Volume
116
Financials
- Market Capitalization 5.74 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-11.58
Price to sales ratio
389.54
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1229 |  PTCT PTC Therapeutics, Inc. - Common Stock | 71.81 USD | -1.21% | +1.80% | -4.06% | +44.14% | 5.99 B USD | ||
| 1245 |  DFTX Definium Therapeutics, Inc. - Common Shares | 43.82 USD | +0.11% | -4.51% | +4.33% | +190.01% | 5.89 B USD | ||
| 1272 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 284.52 USD | -1.16% | -1.24% | -3.43% | +52.05% | 5.67 B USD | ||
| 1341 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.73 USD | +0.51% | +2.24% | +13.82% | +13.52% | 5.12 B USD |
Frequently asked questions about CRISPR Therapeutics AG
What is the CRISPR Therapeutics AG stock price today?
The current price of CRISPR Therapeutics AG (CRSP) is 59.37. Over the past 24 hours, the stock has changed by +0.24%. Follow the CRSP chart for real-time price dynamics.
What is the stock ticker of CRISPR Therapeutics AG?
CRISPR Therapeutics AG trades under the ticker CRSP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is CRISPR Therapeutics AG stock going up?
CRSP has changed by -0.59% over the last week, +25.20% over the last month, and +12.08% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of CRISPR Therapeutics AG?
CRISPR Therapeutics AG currently has a market capitalization of 5.74 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were CRISPR Therapeutics AG earnings last quarter?
Last quarter, CRISPR Therapeutics AG reported earnings of -0.94 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was CRISPR Therapeutics AG revenue for the last quarter?
CRISPR Therapeutics AG reported quarterly revenue of 10.18 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was CRISPR Therapeutics AG net income for the last quarter?
CRISPR Therapeutics AG reported net income of -91.15 M for the last quarter. The previous quarter showed -122.93 M, which means net income changed by +25.85%.
How many employees does CRISPR Therapeutics AG have?
As of the latest available data, CRISPR Therapeutics AG has 393 employees. Workforce size can provide additional context about the company's scale and operations.
What is CRISPR Therapeutics AG EBITDA?
CRISPR Therapeutics AG EBITDA is -112.99 M, and its EBITDA margin is -1 109.8%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy CRISPR Therapeutics AG stock?
You can buy CRISPR Therapeutics AG (CRSP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in CRISPR Therapeutics AG stock?
Investing in CRISPR Therapeutics AG requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRSP chart and related analysis on metatrader.com as part of your research.